Regulation of VSV mrna translation
Active Project Grant Awarded Last action
- Award ID
- F31AI197831
- Recipient
-
Trustees Of Boston University UEI FBYMGMHW4X95
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $100,228
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 3% complete
- Originally
- Place of performance
- Roxbury, MA 02118, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded $100,228 to the Trustees of Boston University (Boston University Medical Campus) on September 27, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to characterize the mechanism of vesicular stomatitis virus (VSV) mRNA translation.
The research uses auxin-inducible degron (AID) systems to systematically probe the requirements of individual translation factors for viral protein synthesis. Prior work demonstrated that VSV mRNAs translate independently of factors necessary for canonical translation, suggesting viral translation occurs through an alternative mechanism. This project aims to identify how non-segmented negative-sense RNA viruses (NSNSVs) accomplish mRNA translation despite possessing structural characteristics—including extremely short 5' untranslated regions and strong stem-loop structures—that would preclude canonical translation initiation and scanning methods. The long-term objective is to expand understanding of NSNSV translation and identify targets for antiviral development.
The award supports the fellowship training and research of a predoctoral scholar under the sponsorship of Dr. Shawn Lyons and co-sponsorship of Dr. John Connor. Training activities include development of skills in biochemistry, translational research methods, and virology; participation in lab meetings, journal clubs, and departmental seminars; and expertise development in RNA biology.
Period of performance runs from September 27, 2026, to May 31, 2029. Work is performed in Roxbury, Massachusetts.
Description
- Abstract
- Project description: viruses are obligate intracellular parasites, as they require access to cellular translation machinery for viral protein synthesis. The order mononegavirales contains non-segmented negative sense RNA viruses (nsnsv). These viruses transcribe positive sense, capped and polyadenylated mrna that are indistinguishable from host transcripts. Due to this, IT is assumed that these viruses use canonical translation machinery. However, the mrna of these viruses possesses characteristics, such as extremely short 5'utrs and strong stem-loop structures, that would preclude canonical translation initiation and scanning methods. Using a series of auxin-inducible degron (aid) systems, we have systematically probed the requirements of individual translation factors for protein synthesis. Vesicular stomatitis virus (VSV) is a member of the mononegavirales order. Its translation has been the most studied of the nsnsvs. We have demonstrated that VSV mrnas translate independently of factors necessary for canonical translation, leading US to believe that viral translation occurs through an alternative mechanism. This proposal aims to characterize the mechanism of VSV translation, a first step to expanding the knowledge of nsnsv translation. Long-term, this work will contribute to increasing the basic understanding of viral replication as well as identifying targets for the development of antivirals. Training plan: i will receive guidance and feedback from my sponsor, DR. Shawn lyons, and CO-sponsor, DR. John connor. In the lab, i will develop and refine my skills in biochemistry, translational research methods, and virology. Participation in regular lab meetings and journal clubs will hone my scientific and critical thinking skills, while attendance at departmental seminars will broaden my understanding of biochemistry and cell biology. Furthermore, i will gain expertise in RNA biology through monthly RNA club meetings, providing a specialized area of focus. I will regularly exercise my presentation skills, presenting in various fostering effective scientific communication skills. This comprehensive training will equip me with a strong foundation in biochemistry, virology, and RNA biology, positioning me for success in my current research endeavor. Further, this will provide me with the expertise necessary to obtain a postdoctoral training fellowship, which will guide me toward my ultimate goal of becoming a principal investigator in an academic setting. Environment: the lyons lab is well-equipped with ample bench space, with various machines at our disposal. These include a chemidoc and turboblot transfer system, for western blotting, and a biocomp, for polysome analysis. We have access to shared spaces that accomadate cold storage and tissue culture. Within the building, we have access to several microscopes and a biorad NGC chromatography system, for protein purification. Additional equipment is available through various core facilities on boston university's medical school and charles river campuses.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $576 | |
| Amendment | $0 | |
| Amendment | $576 | |
| Amendment | $49,538 | |
| Original award | $49,538 |
Quick answers
Who received award F31AI197831?
F31AI197831 was awarded to Trustees Of Boston University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 27, 2026.
How much is award F31AI197831 worth?
$100,228 has been obligated on F31AI197831.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award